日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD8 PET imaging with [(89)Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study

CD8 PET 显像联合 [(89)Zr]Zr-berdoxam-crefmirlimab 用于实体瘤患者:II 期 iCorrelate 研究

Postow, Michael A; Zang, Peter D; Pal, Sumanta K; Mauguen, Audrey; Farwell, Michael; Gordon, Michael; Hays, David; Wong, Jeffrey Y C; Chen, Delphine; Ulaner, Gary A; Esposito, Giuseppe; McConathy, Jonathan; Graham, Michael M; Shields, Anthony F; Van den Abbeele, Annick D; Butler, Marcus O; Thomas, Jacob S; Twardowski, Przemyslaw; Narang, Jayant; Singh, Aman P; Dey, Agnish; Maresca, Kevin P; Keliher, Edmund; Liu, Feng; Potdevin, Guillaume; Schmidt, Guenter; Le, William; Wilson, Ian; Mascioni, Alessandro; Jia, Fang; Korn, Ronald; Ferris, Michael R; Schmiedehausen, Kristin; Pandit-Taskar, Neeta; Margolin, Kim A

Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer

结直肠癌中 II 类和 III 类 BRAF 突变的临床和分子特征

Sahin, Ibrahim Halil; Xiu, Joanne; Baca, Yasmine; Khushman, Moh'd; Grothey, Axel; Palumbo, Emily; Rahman, Shafia; Weinberg, Benjamin A; Goel, Sanjay; Akce, Mehmet; Gorantla, Vikram; Lou, Emil; Kasi, Anup; Shields, Anthony F; Oberley, Matt; Sledge, George; Shen, John Paul; Saeed, Anwaar; Tejani, Mohammedtaki

Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways

MEN1野生型低级别转移性胰腺NET的基因组和转录组图谱揭示了关键的致癌驱动因素和可靶向通路

Uddin, Md Hafiz; Mahdi, Zaid; Muqbil, Irfana; Herring, Brendon R; Rose, Bart; Khan, Husain Y; Li, Yiwei; Aboukameel, Amro; Bannoura, Sahar F; Jimenez, Hugo; Johansen, Allan; Al-Hallak, Mohammad Najeeb; Azar, Ibrahim; Mohamed, Amr; Hadid, Tarik; Vaishampayan, Nitin; Shi, Yang; Wan, Yin; Ong, Vy; Dyson, Gregory; Beydoun, Rafic; Tobon, Miguel; Beal, Eliza W; Chen, Herbert; Shields, Anthony F; Philip, Philip A; Beebe-Dimmer, Jennifer; Mohammad, Ramzi M; Pasche, Boris C; El-Rayes, Bassel F; Azmi, Asfar S

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.

CXCR4 mRNA 过表达:转移性结直肠癌患者生存率低和对免疫检查点抑制剂反应的预测指标。

Gholami Sepideh, Saeed Anwaar, Baca Yasmine, Hinton Andrew, Demyan Lyudmyla, Abidalhassan Mustafa, Xiu Joanne, Manji Gulam A, Seeber Andreas, Weinberg Benjamin A, Khushman Moh'd, Shields Anthony F, Lenz Heinz-Josef, Marshall John, Lou Emil

Clinical and molecular characterization of AXL in colorectal cancer, CALGB (Alliance)/SWOG 80405 and real-world data

CALGB(联盟)/SWOG 80405 和真实世界数据中 AXL 在结直肠癌中的临床和分子特征

Ashouri, Karam; Millstein, Joshua; Yang, Yan; Xiu, Joanne; Soni, Shivani; Mittal, Pooja; Algaze, Sandra; Torres-Gonzalez, Lesly; Jayachandran, Priya; Zhang, Wu; Mumenthaler, Shannon; Shields, Anthony F; Goldberg, Richard; Lou, Emil; Weinberg, Benjamin A; Graeber, Thomas G; Marshall, John L; Venook, Alan P; Hoffmann, Alexander; Finley, Stacey D; Meyer, Aaron S; Battaglin, Francesca; Lenz, Heinz-Josef

Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.

胰腺腺癌中 KRAS 密码子 12 特定变异的独特分子和临床特征

Ardalan Bach, Ciner Aaron, Baca Yasmine, Hinton Andrew, Darabi Sourat, Kasi Anup, Lou Emil, Azqueta Jose Ignacio, Xiu Joanne, Datta Jashodeep, Shields Anthony F, Aguirre Andrew, Singh Harshabad, Shroff Rachna T, Pishvaian Michael J, Goel Sanjay

Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer Patients.

对 16,812 例晚期癌症患者的血浆游离 DNA 变异体进行表征,以确定其是肿瘤来源还是克隆性造血来源

Magee Daniel, Domenyuk Valeriy, Abraham Jim, Perdigones Borderias Nieves, Swensen Jeff, Solipuram Praveena, Ayanambakkam Adanma, Mehdi Raja, Challagalla Jagathi, Heath Elisabeth, Landsverk Megan, Jurkiewicz Magdalena, Shimkus Brian, Pinto Ian, Patterson Daniel, Hsiehchen David, Koya Supriya, Somer Bradley, Velez Michel, Shields Anthony F, Cultrera Jennifer, Ribeiro Jennifer R, Hahn-Lowry Robert, Sledge George W, Oberley Matthew, Radovich Milan, Spetzler David

Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

结肠癌化疗完成率、毒性和生存率的性别差异:对来自 CALGB/SWOG 80702 (Alliance) 的 2201 例患者的分析

Cheng, En; Shi, Qian; Shields, Anthony F; Xue, Xiaonan; Rohan, Thomas E; Kuang, Chaoyuan; Shergill, Ardaman P; Ma, Chao; Couture, Felix; Kuebler, J Philip; Kumar, Pankaj; Tan, Benjamin; Krishnamurthi, Smitha S; Ng, Kimmie; O'Reilly, Eileen M; Brown, Justin C; Meyerhardt, Jeffrey A

The association of physical activity with survival in colon cancer versus a matched general population: Data from Cancer and Leukemia Group B 89803 and 80702 (Alliance)

身体活动与结肠癌患者生存率的相关性(与匹配的一般人群相比):来自癌症和白血病组 B 89803 和 80702(联盟)的数据

Brown, Justin C; Ma, Chao; Shi, Qian; Saltz, Leonard B; Shields, Anthony F; Meyerhardt, Jeffrey A

Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes

结直肠癌患者中MCL-1的全面表征:表达、分子谱和预后

Mittal, Pooja; Battaglin, Francesca; Baca, Yasmine; Xiu, Joanne; Farrell, Alex; Soni, Shivani; Lo, Jae Ho; Torres-Gonzalez, Lesly; Algaze, Sandra; Jayachandran, Priya; Ashouri, Karam; Wong, Alexandra; Zhang, Wu; Yu, Jian; Zhang, Lin; Weinberg, Benjamin A; Lou, Emil; Shields, Anthony F; Goldberg, Richard M; Marshall, John L; Goel, Sanjay; Singh, Indrakant K; Lenz, Heinz-Josef